AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include marketscreener.com, Bloomberg.com, MarketWatch and Seeking Alpha. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 43d ago.
Quick answers
Why is "AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports" trending?
Because 6 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- AbbVie to Reportedly Buy Apogee Therapeutics in $10.9 Billion Deal marketscreener.com · 47d ago
- AbbVie Approaching $11 Billion Deal for Apogee Therapeutics, Report Says Bloomberg.com · 47d ago
- AbbVie would gain an experimental eczema drug by buying biotech: report MarketWatch · 47d ago
- AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics Seeking Alpha · 47d ago
- AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics Financial Times · 47d ago
- AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports Reuters · 47d ago
Topics
Related trends
Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA approves Vera Therapeutics kidney disease treatment
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Scribe Therapeutics seeks $75 million in an IPO, testing market appetite for early-stage biotech.
EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into major pharmaceutical companies regarding the use of clinical trial sites in China.
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.